Postbiotic Bacteriotherapies Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

helminthic therapy

A

an experimental type of immunotherapy, is the treatment of autoimmune diseases and immune disorders by means of deliberate infestation with a helminth or with the eggs of a helminth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the Chinese weight-loss drug ephedra

A

alters the microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

If your microbiome is not intact, three major classifications of cancer drugs absolutely cannot work in the body.

A

These drugs include oligonucleotide therapies, platinum chemotherapy, and cyclophosphamide chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

probiotic rebiosis

A

key word! :)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Probiotics are now viewed as

A

delivery systems for neuroactive compounds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

studies in mice found that treatment with the probiotic bacterium Lactobacillus rhamnosus GG

A

is just as effective in controlling obsessive-compulsive disorder as is the drug Prozac.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

probiotic supplementation in human petrochemical-industry workers

A

was found to reduce their symptoms of depression and anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bacterial metabolites like short-chain fatty acids, tryptophan metabolites, indole metabolites, and sphingolipids

A

will be useful new drugs in the fight against NCDs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

polysaccharide A

A

a component of the bacterium Bacteroides fragilis; can dampen the immune system in cases of autoimmune disease and holds promise for treating diseases such as multiple sclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

short-chain fatty acids (SCFAs)

A

a fermentation product of specific gut bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

sphingolipids produced by gut bacteria can improve brain function and prevent dementia

A

microbiome-based therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Microbial metabolites

A

sugars, fatty acids, and lipid compounds as well as alcohols, ketones, aldehydes, and gases like sulfide and methane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sulfur-containing compounds such as the sulforaphane

A

found in broccoli, Brussels sprouts, kale, mustard greens, and cabbage; reported anticancer qualities and apparent benefits to patients with autism spectrum disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

having a more diverse skin microbiome

A

tended to protect you from the mosquitoes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Staphylococcus bacteria

A

very attractive to mosquitoes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pseudomonas and Variovorax

A

were unattractive; the chemicals our microbes produce

17
Q

competitive exclusion

A

where probiotic bacteria are used to swamp out other less desirable bacteria, proposals have been made to use replacement bacteria in specific body locations (e.g., underarms) as natural deodorants.

18
Q

supplementation with the probiotic bacteria Bifidobacterium bifidum R0071

A

resulted in a higher percentage of healthy days among academically stressed students.

19
Q

consumption of fermented foods containing probiotics

A

was associated with reduced social anxiety.

20
Q

The lower the abundance of Akkermansia muciniphila

A

the thinner a person’s mucus layer, and the more LPS they have in their blood.

21
Q

It is even possible to make people profoundly, though temporarily, depressed

A

by depleting their bodies’ tryptophan supplies.

22
Q

Describe postbiotic bacteriotherapies

A

target downstream signaling pathways of the microbiome and act by mitigating the negative effects of an excess, scarcity, or dysregulation of metabolites involved in these pathways

23
Q

Describe propionate pharmacokinesis

A

Major component of SCFAs

Produced by Clostridia

24
Q

Pharmacokinetics

A

refers to the movement of drug into, through, and out of the body—the time course of its absorption, bioavailability, distribution, metabolism, and excretion.

25
Q

Functional genomics

A

-> the study of how a particular subject will respond to a particular drug​

26
Q

Pharmacogenetics

A

-> the study of variability in drug responses attributed to genetic factors in different populations​

27
Q

Metabolite

A

-> an intermediate or end-product in metabolism reactions​

28
Q

Bioactivation

A

-> conversion of a substance into an active state within a living organism or by a biological system

29
Q

Pharmacogeneticists are primarily interested in

A
  • the genetic variations that alter the ability of the body to absorb, transport, metabolise, or excrete drugs and their metabolites
  • Basically: ‘any genetically determined variation in response to drugs’
  • Even more basically: ‘the genomic information that gives rise to individual drug responses’ ​
  • personalised medicine!!!
30
Q

Combinatorial pharmacogenetics is essentially

A

the ‘interrogation’ (hybridization) of a candidate pathway to identify the loci that modulate a drug response ​

31
Q

Differing drug responses

A

‘external compounds have to follow a succession of oxidation reactions and conjugations by metabolizing and transporting enzymes to be assimilated and then secreted by an organism’​

32
Q

Pharmokinetics has 4 components:

A

absorption, distribution, metabolism and excretion (ADME) ​

33
Q

Absorption

A

-> how the drug enters the bloodstream after taking pill/inhalant (note! Intravenous injection circumvents absorption by putting the drug directly into the blood)​

34
Q

Distribution

A

-> where the drug travels after absorption, and how much reaches the target site (can be hindered, for example by BBB) ​

35
Q

‘high risk pharmacokinetics’

A

-> when a drug is metabolized by a single pathway ​

36
Q

Scenario 1: the prodrug must be metabolized (undergo bioactivation)​
What can go wrong?

A

i) poor metabolisers suffer decreased efficacy or ii) if multiple drugs that inhibit bioactivating systems are administered at once, an extensive metaboliser produces a ’phenocopy’ of a poor metaboliser ​

37
Q

Scenario 2: the substrate drug undergoes bioinactivation via a single metabolic pathway ​
What can go wrong?

A

If this pathway is faulty, the active parent drug will accumulate in much higher concentrations

38
Q

Personalised medicine

A
  • ‘pre-prescription genotyping’ or ‘pre-emptive genotyping’, where prescriptions can be made on readily-available genotype data at your GP ​
  • GP could then observe your gene variants, which are their associated drug responses, and hence decide drug type and dosage for maximum efficacy and to avoid adverse drug reactions ​
  • use of genotypes as entry and stratification criterion in clinical trials